These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3089949)

  • 41. Absolute and relative bioavailability of lithium dosage forms in the beagle dog.
    Banarer M; Ritschel WA
    Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients after acute dosage.
    Thornhill DP
    Eur J Clin Pharmacol; 1978 Dec; 14(4):267-71. PubMed ID: 365541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a slow-release lithium carbonate formulation.
    Cooper TB; Simpson GM; Lee JH; Bergner PE
    Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development and pharmacokinetic study of metoprolol tartrate controlled-release tablet remaining-floating in stomach].
    Li SL; Tu XD; Mao FF
    Yao Xue Xue Bao; 1989; 24(5):381-6. PubMed ID: 2609974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man.
    Terhaag B; Scherber A; Schaps P; Winkler H
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):333-5. PubMed ID: 669880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of three different diets on the bioavailability of a sustained release lithium carbonate matrix tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):320-6. PubMed ID: 10890582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption & urinary & salivary excretion of lithium after oral administration.
    Doshi BS; Rout SJ; Kulkarni RD
    Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533
    [No Abstract]   [Full Text] [Related]  

  • 52. Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets.
    Guelen PJ; Janssen TJ; De Witte TC; Vree TB; Benson K
    Biopharm Drug Dispos; 1992 Oct; 13(7):503-11. PubMed ID: 1489941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of lithium in the dog.
    Rosenthal RC; Koritz GD; Davis LE
    J Vet Pharmacol Ther; 1986 Mar; 9(1):81-7. PubMed ID: 3009841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma and intracellular kinetics of lithium after oral administration of various lithium salts.
    Altamura AC; Gomeni R; Sacchetti E; Smeraldi E
    Eur J Clin Pharmacol; 1977 Aug; 12(1):59-63. PubMed ID: 902676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability.
    Gai MN; Ferj S; García E; Seitz C; Thielemann AM; Andonaegui MT
    Drug Dev Ind Pharm; 1999 Feb; 25(2):131-40. PubMed ID: 10065346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics of lithium in normal humans: expected and unexpected observations in view of basic kinetic principles.
    Luisier PA; Schulz P; Dick P
    Pharmacopsychiatry; 1987 Sep; 20(5):232-4. PubMed ID: 3118402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
    Shelley RK; Silverstone T
    Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of lithium in human plasma and erythrocytes.
    Poust RI; Mallinger AG; Mallinger J; Himmelhoch JM; Hanin I
    Psychopharmacol Commun; 1976; 2(2):91-103. PubMed ID: 981712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.